Supplementation with carnitine has demonstrated improvements in various parameters in patients with NAFLD, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), triglyceride (TG) levels, and the homeostatic model assessment of IR (HOMA‐IR). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.